FBR Capital Reiterates an 'Outperform' on BioMed Realty (BMR); Leasing Momentum Should Continue
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Price: $5.52 -4.83%
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
FBR Capital reiterates an 'Outperform' on BioMed Realty (NYSE: BMR), PT $21.
FBR analyst says, "Our investment thesis on shares of BMR remains focused on what appears to be an attractive entry point in an improving lab space environment. Although we believe a 10% premium to our NAV estimate of $19.00 is warranted due to good balance sheet strength, capital markets access, and external growth, we continue to expect a high level of tenant move-out risk and near-term slow fundamental growth."
"Our 2011 and 2012 FFO per share estimates remain unchanged at $1.15 and $1.27 respectively, while we are increasing our 2013 FFO per share estimate to $1.38 from $1.36, and introducing our 2014 FFO per share estimate of $1.48."
For more ratings news on BioMed Realty click here and for the rating history of BioMed Realty click here.
Shares of BioMed Realty closed at $19.76 yesterday.
FBR analyst says, "Our investment thesis on shares of BMR remains focused on what appears to be an attractive entry point in an improving lab space environment. Although we believe a 10% premium to our NAV estimate of $19.00 is warranted due to good balance sheet strength, capital markets access, and external growth, we continue to expect a high level of tenant move-out risk and near-term slow fundamental growth."
"Our 2011 and 2012 FFO per share estimates remain unchanged at $1.15 and $1.27 respectively, while we are increasing our 2013 FFO per share estimate to $1.38 from $1.36, and introducing our 2014 FFO per share estimate of $1.48."
For more ratings news on BioMed Realty click here and for the rating history of BioMed Realty click here.
Shares of BioMed Realty closed at $19.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades Feng Tay Enterprises (9910:TT) to Hold
- QuantumScape (QS) PT Lowered to $6 at Truist Securities
- CIMC Enric Holdings Ltd. (3899:HK) (CIMEF) PT Lowered to HK$8.70 at HSBC
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
